The Drug Check eTEN Project

Drug CheckThe objective of the Drug Check project is to validate an on-line, pan-European service, which gathers, organises, stores, makes available and presents information and data covering pharmaceuticals and their interactions. The service provides a user-friendly, reliable, intelligent and fast mechanism to accept questions and advanced queries, process them and offer accurate answers justified with the relevant bibliography, in order to assist healthcare professionals in making the proper decisions on medication prescriptions and pharmaceutical treatments both in and out of the hospital without interrupting healthcare delivery.

The service will be offered as a web-based/mobile application to healthcare professionals and institutions (e.g. hospitals, research organisations) following the ASP (application service provider) model, and its functionality will facilitate users to gain optimum access to the service at any time, from any place using various devices (computer, mobile phones, etc), at low cost and with enhanced userfriendliness and usability, in order to become a fast, reliable, accurate and effective companion to their everyday practise. A consortium of academic experts, IT integrators and Consulting companies will offer the service via Internet and mobile platforms to healthcare professionals.

It is envisaged that the service, after its deployment, will be an invaluable companion to a wide range of healthcare professionals, by enhancing their skills and empowering their decision-making processes, thus reducing unwanted effects and improving cost-effectiveness of patients' treatment and therefore contributing to better healthcare services for all citizens.

The DrugCheck service can be a valuable tool to all healthcare professionals who want fast access to trusted and verified information (through latest bibliography and publications) about potential interactions between pharmaceuticals. The service is not limited to the information offered from the drug's documentation provided from the company but offers information on mechanisms and results of interactions between pharmaceuticals.

DrugCheck service offers the following functionality:

  • Drug Interactions: The service describes the various types of interactions between pharmaceuticals (and also nutritional elements).
  • Detailed description of the interaction mechanism and the mechanism in case of special patients groups, location of interaction, pharmacokinetic properties etc.
  • Reference to the necessity of the measurement of the levels of some of the medicines already administered or scheduled to be administered to the patient, in order to decide the right dose of the medicine to minimise the risk of potential interactions
  • Effect of interaction and management of effects
  • References to source of knowledge (bibliography) and links to documentation.

For further information, please visit:
http://www.drug-check.org

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...